| Salah E Aboubakr, MD | |
|
405 W Greenlawn Ave Ste 130a, Lansing, MI 48910-0812 | |
| (571) 574-5605 | |
| Not Available |
| Full Name | Salah E Aboubakr |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 35 Years |
| Location | 405 W Greenlawn Ave Ste 130a, Lansing, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235249772 | NPI | - | NPPES |
| 036107820 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 4301072003 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mclaren Greater Lansing | Lansing, MI | Hospital |
| Edward W Sparrow Hospital | Lansing, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capitol Area Pulmonary Associates Pc | 3274856547 | 2 |
News Archive
GE Healthcare shares a suite of advances in imaging quantitation that may help clinicians diagnose disease earlier, deliver more personalised treatment and speed up care at the 27th annual meeting of the European Association of Nuclear Medicine (EANM), 18-22 October, in Gothenburg.
Adherent Health, LLC, a mobile health engagement advisory focused on medication safe-use, adherence, and health outcomes attainment, announced today the results of its 2014 Patient Preference Study which surveyed the mobile app behaviors and medication support preferences of 2,216 prescription-taking patients aged 18-65+.
Novartis Pharmaceuticals Canada Inc. (Novartis) announced today that Afinitor(R) (everolimus), a once-daily oral cancer treatment, has been approved by Health Canada for patients with metastatic renal cell carcinoma (mRCC), also known as advanced kidney cancer, after failure of initial treatment with VEGF-receptor targeted therapies Sutent(R) (sunitinib) or Nexavar(R) (sorafenib).
Springer has launched a new open access journal, the International Journal of Implant Dentistry. Sponsored by the German Association of Dental Implantology and the Japanese Socieities of Oral Implantology, and published by SpringerOpen, the journal is dedicated to the exchange and discussion of new research in the field of implant dentistry.
BIOREM Inc. is pleased to announce the final closing of its private placement. In the initial closing, a total of 535 Units were issued for gross proceeds of $535,000.
› Verified 1 days ago
| Entity Name | Capitol Area Pulmonary Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578967634 PECOS PAC ID: 3274856547 Enrollment ID: O20141218001334 |
News Archive
GE Healthcare shares a suite of advances in imaging quantitation that may help clinicians diagnose disease earlier, deliver more personalised treatment and speed up care at the 27th annual meeting of the European Association of Nuclear Medicine (EANM), 18-22 October, in Gothenburg.
Adherent Health, LLC, a mobile health engagement advisory focused on medication safe-use, adherence, and health outcomes attainment, announced today the results of its 2014 Patient Preference Study which surveyed the mobile app behaviors and medication support preferences of 2,216 prescription-taking patients aged 18-65+.
Novartis Pharmaceuticals Canada Inc. (Novartis) announced today that Afinitor(R) (everolimus), a once-daily oral cancer treatment, has been approved by Health Canada for patients with metastatic renal cell carcinoma (mRCC), also known as advanced kidney cancer, after failure of initial treatment with VEGF-receptor targeted therapies Sutent(R) (sunitinib) or Nexavar(R) (sorafenib).
Springer has launched a new open access journal, the International Journal of Implant Dentistry. Sponsored by the German Association of Dental Implantology and the Japanese Socieities of Oral Implantology, and published by SpringerOpen, the journal is dedicated to the exchange and discussion of new research in the field of implant dentistry.
BIOREM Inc. is pleased to announce the final closing of its private placement. In the initial closing, a total of 535 Units were issued for gross proceeds of $535,000.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Salah E Aboubakr, MD 405 W Greenlawn Ave Ste 130a, Lansing, MI 48910-0812 Ph: (571) 574-5605 | Salah E Aboubakr, MD 405 W Greenlawn Ave Ste 130a, Lansing, MI 48910-0812 Ph: (571) 574-5605 |
News Archive
GE Healthcare shares a suite of advances in imaging quantitation that may help clinicians diagnose disease earlier, deliver more personalised treatment and speed up care at the 27th annual meeting of the European Association of Nuclear Medicine (EANM), 18-22 October, in Gothenburg.
Adherent Health, LLC, a mobile health engagement advisory focused on medication safe-use, adherence, and health outcomes attainment, announced today the results of its 2014 Patient Preference Study which surveyed the mobile app behaviors and medication support preferences of 2,216 prescription-taking patients aged 18-65+.
Novartis Pharmaceuticals Canada Inc. (Novartis) announced today that Afinitor(R) (everolimus), a once-daily oral cancer treatment, has been approved by Health Canada for patients with metastatic renal cell carcinoma (mRCC), also known as advanced kidney cancer, after failure of initial treatment with VEGF-receptor targeted therapies Sutent(R) (sunitinib) or Nexavar(R) (sorafenib).
Springer has launched a new open access journal, the International Journal of Implant Dentistry. Sponsored by the German Association of Dental Implantology and the Japanese Socieities of Oral Implantology, and published by SpringerOpen, the journal is dedicated to the exchange and discussion of new research in the field of implant dentistry.
BIOREM Inc. is pleased to announce the final closing of its private placement. In the initial closing, a total of 535 Units were issued for gross proceeds of $535,000.
› Verified 1 days ago
Aline De Quadros Teixeira, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1200 E Michigan Ave Ste 500, Lansing, MI 48912 Phone: 517-364-5184 | |
Dr. Harry James Mccoy, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1540 Lake Lansing Rd, Ste 201, Lansing, MI 48912 Phone: 517-913-3900 Fax: 517-913-3901 | |
Ali H. Sheikh, D.O Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1140 E Michigan Ave Ste 400, Lansing, MI 48912 Phone: 517-364-9650 Fax: 517-364-9605 | |
Georgette Nader, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1215 E Michigan Ave, Lansing, MI 48912 Phone: 517-253-8366 | |
Salma Mohamed, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1215 E Michigan Ave, Lansing, MI 48912 Phone: 517-364-1000 | |
Dr. Cynthia S. Boynton, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1540 Lake Lansing Rd, Ste 201, Lansing, MI 48912 Phone: 517-913-3900 Fax: 517-913-3901 | |
Fadi Mohammadsaeed S Alreefi, M.D Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1140 E Michigan Ave Ste 400, Lansing, MI 48912 Phone: 419-921-2531 Fax: 517-364-9605 |